LAVA Therapeutics Ownership 2024 | Who Owns LAVA Therapeutics Now?
Institutional Ownership
14.03%
Insider Ownership
28.72%
Retail Ownership
57.25%
Institutional Holders
20.00
LAVA Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| REDMILE GROUP, LLC | 7.74% | 0.23% | 2,074,372 | - | - | 3,733,870 | Jun 30, 2024 |
| BRUCE & CO., INC. | 2.88% | 0.46% | 771,874 | - | - | 1,389,373 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 1.37% | 0.09% | 367,582 | - | - | 661,648 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.42% | 0.00% | 112,439 | 30,408 | 37.07% | 202,390 | Jun 30, 2024 |
| ALPHA WAVE GLOBAL, LP | 0.33% | 0.05% | 87,397 | -20,509 | -19.01% | 157,315 | Jun 30, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | 0.24% | 0.00% | 65,000 | - | - | 117,000 | Jun 30, 2024 |
| PATHWAY FINANCIAL ADVISORS LLC | 0.22% | 0.03% | 60,000 | 46,000 | 328.57% | 108,000 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.12% | 0.00% | 30,807 | 30,807 | 100.00% | 55,453 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.10% | - | 26,493 | 6,465 | 32.28% | 47,687 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | 0.10% | 0.00% | 25,675 | -128,991 | -83.40% | 46,215 | Jun 30, 2024 |
| MORGAN STANLEY | 0.06% | - | 15,600 | 5,400 | 52.94% | 28,080 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.04% | - | 11,124 | - | - | 20,023 | Jun 30, 2024 |
| CIBC PRIVATE WEALTH GROUP, LLC | 0.02% | - | 6,000 | - | - | 11,100 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 0.02% | 0.00% | 5,109 | 5,109 | 100.00% | 9,196 | Jun 30, 2024 |
| TSFG, LLC | 0.00% | 0.00% | 400 | - | - | 1,000 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.00% | - | 400 | -15,011 | -97.40% | 720 | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -12,908 | -100.00% | - | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -2,589 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | - | - | - | -8,980 | -100.00% | - | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | - | - | - | -18,300 | -100.00% | - | Jun 30, 2024 |
LAVA Therapeutics's largest institutional shareholder is REDMILE GROUP, LLC, holding 7.74% of the company's total share outstanding, currently valued at $3.73M. The top 10 institutional shareholders own together 13.52% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BRUCE & CO., INC. | 2.88% | 0.46% | 771,874 | - | - | 1,389,373 | Jun 30, 2024 |
| REDMILE GROUP, LLC | 7.74% | 0.23% | 2,074,372 | - | - | 3,733,870 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 1.37% | 0.09% | 367,582 | - | - | 661,648 | Jun 30, 2024 |
| ALPHA WAVE GLOBAL, LP | 0.33% | 0.05% | 87,397 | -20,509 | -19.01% | 157,315 | Jun 30, 2024 |
| PATHWAY FINANCIAL ADVISORS LLC | 0.22% | 0.03% | 60,000 | 46,000 | 328.57% | 108,000 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.12% | 0.00% | 30,807 | 30,807 | 100.00% | 55,453 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 0.02% | 0.00% | 5,109 | 5,109 | 100.00% | 9,196 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.42% | 0.00% | 112,439 | 30,408 | 37.07% | 202,390 | Jun 30, 2024 |
| TSFG, LLC | 0.00% | 0.00% | 400 | - | - | 1,000 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | 0.10% | 0.00% | 25,675 | -128,991 | -83.40% | 46,215 | Jun 30, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | 0.24% | 0.00% | 65,000 | - | - | 117,000 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.10% | - | 26,493 | 6,465 | 32.28% | 47,687 | Jun 30, 2024 |
| CIBC PRIVATE WEALTH GROUP, LLC | 0.02% | - | 6,000 | - | - | 11,100 | Jun 30, 2024 |
| MORGAN STANLEY | 0.06% | - | 15,600 | 5,400 | 52.94% | 28,080 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.04% | - | 11,124 | - | - | 20,023 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.00% | - | 400 | -15,011 | -97.40% | 720 | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -12,908 | -100.00% | - | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -2,589 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | - | - | - | -8,980 | -100.00% | - | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | - | - | - | -18,300 | -100.00% | - | Jun 30, 2024 |
The largest LAVA Therapeutics shareholder by % of total assets is BRUCE & CO., INC.. The company owns 771.87K shares of LAVA Therapeutics (LVTX), representing 0.46% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PATHWAY FINANCIAL ADVISORS LLC | 0.22% | 0.03% | 60,000 | 46,000 | 328.57% | 108,000 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.12% | 0.00% | 30,807 | 30,807 | 100.00% | 55,453 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.42% | 0.00% | 112,439 | 30,408 | 37.07% | 202,390 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.10% | - | 26,493 | 6,465 | 32.28% | 47,687 | Jun 30, 2024 |
| MORGAN STANLEY | 0.06% | - | 15,600 | 5,400 | 52.94% | 28,080 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 0.02% | 0.00% | 5,109 | 5,109 | 100.00% | 9,196 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.04% | - | 11,124 | - | - | 20,023 | Jun 30, 2024 |
| CIBC PRIVATE WEALTH GROUP, LLC | 0.02% | - | 6,000 | - | - | 11,100 | Jun 30, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | 0.24% | 0.00% | 65,000 | - | - | 117,000 | Jun 30, 2024 |
| TSFG, LLC | 0.00% | 0.00% | 400 | - | - | 1,000 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 1.37% | 0.09% | 367,582 | - | - | 661,648 | Jun 30, 2024 |
| REDMILE GROUP, LLC | 7.74% | 0.23% | 2,074,372 | - | - | 3,733,870 | Jun 30, 2024 |
| BRUCE & CO., INC. | 2.88% | 0.46% | 771,874 | - | - | 1,389,373 | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -2,589 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | - | - | - | -8,980 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -12,908 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.00% | - | 400 | -15,011 | -97.40% | 720 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | - | - | - | -18,300 | -100.00% | - | Jun 30, 2024 |
| ALPHA WAVE GLOBAL, LP | 0.33% | 0.05% | 87,397 | -20,509 | -19.01% | 157,315 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | 0.10% | 0.00% | 25,675 | -128,991 | -83.40% | 46,215 | Jun 30, 2024 |
As of Jun 30 2024, LAVA Therapeutics's largest institutional buyer is PATHWAY FINANCIAL ADVISORS LLC. The company purchased 46.00K stocks of LVTX, valued at $108.00K.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| WALLEYE CAPITAL LLC | 0.10% | 0.00% | 25,675 | -128,991 | -83.40% | 46,215 | Jun 30, 2024 |
| ALPHA WAVE GLOBAL, LP | 0.33% | 0.05% | 87,397 | -20,509 | -19.01% | 157,315 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | - | - | - | -18,300 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.00% | - | 400 | -15,011 | -97.40% | 720 | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -12,908 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | - | - | - | -8,980 | -100.00% | - | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -2,589 | -100.00% | - | Jun 30, 2024 |
| BRUCE & CO., INC. | 2.88% | 0.46% | 771,874 | - | - | 1,389,373 | Jun 30, 2024 |
| REDMILE GROUP, LLC | 7.74% | 0.23% | 2,074,372 | - | - | 3,733,870 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 1.37% | 0.09% | 367,582 | - | - | 661,648 | Jun 30, 2024 |
| TSFG, LLC | 0.00% | 0.00% | 400 | - | - | 1,000 | Jun 30, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | 0.24% | 0.00% | 65,000 | - | - | 117,000 | Jun 30, 2024 |
| CIBC PRIVATE WEALTH GROUP, LLC | 0.02% | - | 6,000 | - | - | 11,100 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.04% | - | 11,124 | - | - | 20,023 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 0.02% | 0.00% | 5,109 | 5,109 | 100.00% | 9,196 | Jun 30, 2024 |
| MORGAN STANLEY | 0.06% | - | 15,600 | 5,400 | 52.94% | 28,080 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.10% | - | 26,493 | 6,465 | 32.28% | 47,687 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.42% | 0.00% | 112,439 | 30,408 | 37.07% | 202,390 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.12% | 0.00% | 30,807 | 30,807 | 100.00% | 55,453 | Jun 30, 2024 |
| PATHWAY FINANCIAL ADVISORS LLC | 0.22% | 0.03% | 60,000 | 46,000 | 328.57% | 108,000 | Jun 30, 2024 |
As of Jun 30 2024, LAVA Therapeutics's biggest institutional seller is WALLEYE CAPITAL LLC. The company sold -0.13M shares of LVTX, valued at $46.22K.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| XTX TOPCO LTD | 0.12% | 0.00% | 30,807 | 30,807 | 100.00% | 55,453 | Jun 30, 2024 |
LAVA Therapeutics's largest new institutional shareholder by number of shares is XTX TOPCO LTD, purchased 30.81K shares, valued at $55.45K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SCHONFELD STRATEGIC ADVISORS LLC | - | - | - | -18,300 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -12,908 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | - | - | - | -8,980 | -100.00% | - | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -2,589 | -100.00% | - | Jun 30, 2024 |
LAVA Therapeutics's largest sold out institutional shareholder by shares sold is SCHONFELD STRATEGIC ADVISORS LLC, sold -18.30K shares, valued at -, as of undefined.
LAVA Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| BRUCE FUND INC | 0.37% | 771,874 | - | - | Dec 31, 2023 |
| Advisors' Inner Circle Fund III | 0.00% | 24,423 | - | - | Jan 31, 2024 |
LAVA Therapeutics's largest mutual fund holder by % of total assets is "BRUCE FUND INC", owning 771.87K shares, compromising 0.37% of its total assets.
LAVA Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 20 | -13.04% |
| 31 Mar, 24 | 23 | 64.29% |
| 31 Dec, 23 | 14 | - |
| 30 Sep, 23 | 14 | -12.50% |
| 30 Jun, 23 | 16 | -15.79% |
| 31 Mar, 23 | 19 | -5.00% |
| 31 Dec, 22 | 20 | 66.67% |
| 30 Sep, 22 | 12 | -25.00% |
| 30 Jun, 22 | 16 | - |
| 31 Mar, 22 | 16 | -11.11% |
| 31 Dec, 21 | 18 | - |
| 30 Sep, 21 | 18 | - |
| 30 Jun, 21 | 18 | -25.00% |
| 31 Mar, 21 | 24 | - |
As of 30 Jun 24, 20 institutions are holding LAVA Therapeutics's shares, representing a decrease of -13.04% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 3,758,209 | -0.08% |
| 31 Mar, 24 | 3,761,071 | -35.55% |
| 31 Dec, 23 | 5,835,438 | 2.05% |
| 30 Sep, 23 | 5,718,284 | -0.49% |
| 30 Jun, 23 | 5,746,405 | -14.73% |
| 31 Mar, 23 | 6,739,420 | -10.46% |
| 31 Dec, 22 | 7,526,999 | 1.00% |
| 30 Sep, 22 | 7,452,823 | -4.93% |
| 30 Jun, 22 | 7,839,304 | -1.95% |
| 31 Mar, 22 | 7,995,442 | -0.73% |
| 31 Dec, 21 | 8,054,131 | -1.99% |
| 30 Sep, 21 | 8,217,829 | -6.33% |
| 30 Jun, 21 | 8,772,945 | -4.88% |
| 31 Mar, 21 | 9,222,819 | - |
LAVA Therapeutics (LVTX) has 3.76M shares outstanding as of 30 Jun 24, down -0.08% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 14.03% | 7.11% |
| 31 Mar, 24 | 14.05% | 2.85% |
| 31 Dec, 23 | 22.20% | 4.69% |
| 30 Sep, 23 | 21.75% | 4.55% |
| 30 Jun, 23 | 21.86% | 3.33% |
| 31 Mar, 23 | 25.64% | 3.04% |
| 31 Dec, 22 | 29.03% | 3.49% |
| 30 Sep, 22 | 28.84% | 3.12% |
| 30 Jun, 22 | 30.41% | 3.16% |
| 31 Mar, 22 | 31.02% | 1.87% |
| 31 Dec, 21 | 40.76% | 4.01% |
| 30 Sep, 21 | 31.88% | 2.70% |
| 30 Jun, 21 | 34.37% | 2.63% |
| 31 Mar, 21 | 36.13% | - |
As of 30 Jun 24, LAVA Therapeutics is held by 14.03% institutional shareholders, representing a 7.11% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 8 | -38.46% |
| 31 Mar, 24 | 13 | 225.00% |
| 31 Dec, 23 | 4 | 300.00% |
| 30 Sep, 23 | 1 | -88.89% |
| 30 Jun, 23 | 9 | 28.57% |
| 31 Mar, 23 | 7 | -30.00% |
| 31 Dec, 22 | 10 | 150.00% |
| 30 Sep, 22 | 4 | 100.00% |
| 30 Jun, 22 | 2 | -33.33% |
| 31 Mar, 22 | 3 | -25.00% |
| 31 Dec, 21 | 4 | -42.86% |
| 30 Sep, 21 | 7 | -12.50% |
| 30 Jun, 21 | 8 | -66.67% |
| 31 Mar, 21 | 24 | - |
8 institutional shareholders have increased their position in LVTX stock as of 30 Jun 24 compared to 13 in the previous quarter (a -38.46% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 3 | - |
| 31 Mar, 24 | 3 | -25.00% |
| 31 Dec, 23 | 4 | 100.00% |
| 30 Sep, 23 | 2 | - |
| 30 Jun, 23 | 2 | -66.67% |
| 31 Mar, 23 | 6 | 50.00% |
| 31 Dec, 22 | 4 | 100.00% |
| 30 Sep, 22 | 2 | -75.00% |
| 30 Jun, 22 | 8 | 100.00% |
| 31 Mar, 22 | 4 | -33.33% |
| 31 Dec, 21 | 6 | - |
| 30 Sep, 21 | 6 | -14.29% |
| 30 Jun, 21 | 7 | - |
| 31 Mar, 21 | - | - |
3 institutional shareholders have reduced their position in LVTX stock as of 30 Jun 24 compared to 3 in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 20 | -13.04% | 3,758,209 | -0.08% | 14.03% | 7.11% | 8 | -38.46% | 3 | - |
| 31 Mar, 24 | 23 | 64.29% | 3,761,071 | -35.55% | 14.05% | 2.85% | 13 | 225.00% | 3 | -25.00% |
| 31 Dec, 23 | 14 | - | 5,835,438 | 2.05% | 22.20% | 4.69% | 4 | 300.00% | 4 | 100.00% |
| 30 Sep, 23 | 14 | -12.50% | 5,718,284 | -0.49% | 21.75% | 4.55% | 1 | -88.89% | 2 | - |
| 30 Jun, 23 | 16 | -15.79% | 5,746,405 | -14.73% | 21.86% | 3.33% | 9 | 28.57% | 2 | -66.67% |
| 31 Mar, 23 | 19 | -5.00% | 6,739,420 | -10.46% | 25.64% | 3.04% | 7 | -30.00% | 6 | 50.00% |
| 31 Dec, 22 | 20 | 66.67% | 7,526,999 | 1.00% | 29.03% | 3.49% | 10 | 150.00% | 4 | 100.00% |
| 30 Sep, 22 | 12 | -25.00% | 7,452,823 | -4.93% | 28.84% | 3.12% | 4 | 100.00% | 2 | -75.00% |
| 30 Jun, 22 | 16 | - | 7,839,304 | -1.95% | 30.41% | 3.16% | 2 | -33.33% | 8 | 100.00% |
| 31 Mar, 22 | 16 | -11.11% | 7,995,442 | -0.73% | 31.02% | 1.87% | 3 | -25.00% | 4 | -33.33% |
| 31 Dec, 21 | 18 | - | 8,054,131 | -1.99% | 40.76% | 4.01% | 4 | -42.86% | 6 | - |
| 30 Sep, 21 | 18 | - | 8,217,829 | -6.33% | 31.88% | 2.70% | 7 | -12.50% | 6 | -14.29% |
| 30 Jun, 21 | 18 | -25.00% | 8,772,945 | -4.88% | 34.37% | 2.63% | 8 | -66.67% | 7 | - |
| 31 Mar, 21 | 24 | - | 9,222,819 | - | 36.13% | - | 24 | - | - | - |
LAVA Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| PMVP | PMV Pharmaceuticals, Inc. |
| ACHL | Achilles Therapeutics plc |
| NXTC | NextCure, Inc. |
| IKNA | Ikena Oncology, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| AVTE | Aerovate Therapeutics, Inc. |
| ACRV | Acrivon Therapeutics, Inc. Common Stock |
| ERAS | Erasca, Inc. |
| GBIO | Generation Bio Co. |
| KRON | Kronos Bio, Inc. |
| ANTX | AN2 Therapeutics, Inc. |
| CCCC | C4 Therapeutics, Inc. |
| ASMB | Assembly Biosciences, Inc. |
| DSGN | Design Therapeutics, Inc. |
| RZLT | Rezolute, Inc. |
| ANEB | Anebulo Pharmaceuticals, Inc. |
| BNOX | Bionomics Limited |
| XLO | Xilio Therapeutics, Inc. |
| ADAG | Adagene Inc. |
| NLTX | Neurogene Inc. |
| TIL | Instil Bio, Inc. |
| ELYM | Eliem Therapeutics, Inc. |
LVTX Ownership FAQ
Who Owns LAVA Therapeutics?
LAVA Therapeutics is owned by institutional shareholders (14.03%), insiders (28.72%), and public (57.25%). The largest institutional shareholder of LAVA Therapeutics is REDMILE GROUP, LLC (7.74% of total shares) and the top mutual fund owner is BRUCE FUND INC (0.37% of total shares).
Who are the major institutional shareholders of LAVA Therapeutics?
LAVA Therapeutics's major institutional shareholders are REDMILE GROUP, LLC, BRUCE & CO., INC., SPHERA FUNDS MANAGEMENT LTD., TWO SIGMA INVESTMENTS, LP, and ALPHA WAVE GLOBAL, LP. The top five shareholders own together 12.74% of the company's share outstanding.
How many LAVA Therapeutics shareholders are there?
As of Jun 2024, there are 20 institutional shareholders of LAVA Therapeutics.
What percentage of LAVA Therapeutics is owned by REDMILE GROUP, LLC?
REDMILE GROUP, LLC owns 2.07M shares of LAVA Therapeutics, representing 7.74% of the company's total shares outstanding, valued at $3.73M (as of Jun 2024).
What percentage of LAVA Therapeutics is owned by BRUCE & CO., INC?
As of Jun 2024, BRUCE & CO., INC holds 771.87K shares of LAVA Therapeutics (LVTX), compromising 2.88% of the company, valued at $1.39M.
What percentage of LAVA Therapeutics is owned by SPHERA FUNDS MANAGEMENT LTD?
SPHERA FUNDS MANAGEMENT LTD is the third largest holder of LAVA Therapeutics. The company owns 367.58K of the company's shares outstanding (worth $661.65K).